25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

GUFIC BIOSCIENCES LTD.
Buy, Hold or Sell?

Let's analyze Gufic together

I guess you are interested in GUFIC BIOSCIENCES LTD.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of GUFIC BIOSCIENCES LTD.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about GUFIC BIOSCIENCES LTD.

I send you an email if I find something interesting about GUFIC BIOSCIENCES LTD..

1. Quick Overview

1.1. Quick analysis of Gufic (30 sec.)










1.2. What can you expect buying and holding a share of Gufic? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
INR53.11
Expected worth in 1 year
INR126.80
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
INR74.08
Return On Investment
18.4%

For what price can you sell your share?

Current Price per Share
INR403.15
Expected price per share
INR354.56 - INR501.10
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Gufic (5 min.)




Live pricePrice per Share (EOD)
INR403.15
Intrinsic Value Per Share
INR-319.04 - INR-142.01
Total Value Per Share
INR-265.93 - INR-88.90

2.2. Growth of Gufic (5 min.)




Is Gufic growing?

Current yearPrevious yearGrowGrow %
How rich?$62.8m$41m$21.8m34.7%

How much money is Gufic making?

Current yearPrevious yearGrowGrow %
Making money$10.1m$9.4m$758.8k7.5%
Net Profit Margin10.7%11.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Gufic (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Gufic?

Welcome investor! Gufic's management wants to use your money to grow the business. In return you get a share of Gufic.

First you should know what it really means to hold a share of Gufic. And how you can make/lose money.

Speculation

The Price per Share of Gufic is INR403.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Gufic.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Gufic, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR53.11. Based on the TTM, the Book Value Change Per Share is INR18.42 per quarter. Based on the YOY, the Book Value Change Per Share is INR7.85 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.10 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Gufic.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps0.100.0%0.100.0%0.090.0%0.080.0%0.070.0%
Usd Book Value Change Per Share0.220.1%0.220.1%0.090.0%0.110.0%0.100.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.220.1%0.220.1%0.090.0%0.110.0%0.110.0%
Usd Price Per Share3.34-3.34-2.20-2.08-1.88-
Price to Earnings Ratio32.96-32.96-23.48-25.85-27.33-
Price-to-Total Gains Ratio15.29-15.29-23.47-20.37-18.65-
Price to Book Ratio5.33-5.33-5.38-6.31-6.94-
Price-to-Total Gains Ratio15.29-15.29-23.47-20.37-18.65-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share4.75717
Number of shares210
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.220.11
Usd Total Gains Per Share0.220.11
Gains per Quarter (210 shares)45.8922.78
Gains per Year (210 shares)183.5891.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1118317419081
223653581181172
335485422271263
447307263362354
559139104452445
66109610944542536
77127812785633627
88146114626723718
99164416467813809
1010182618307904900

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%6.00.00.0100.0%6.00.00.0100.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of GUFIC BIOSCIENCES LTD. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--18.42418.4240%7.847+135%9.119+102%8.851+108%
Book Value Per Share--53.10853.1080%34.684+53%28.297+88%24.833+114%
Current Ratio--1.6141.6140%1.610+0%1.535+5%1.487+9%
Debt To Asset Ratio--0.5130.5130%0.596-14%0.576-11%0.602-15%
Debt To Equity Ratio--1.0511.0510%1.476-29%1.488-29%1.692-38%
Dividend Per Share--0.0970.0970%0.104-7%0.075+28%0.069+39%
Eps--8.5908.5900%7.948+8%6.554+31%5.826+47%
Free Cash Flow Per Share---12.082-12.0820%-21.359+77%-4.772-61%-4.108-66%
Free Cash Flow To Equity Per Share---12.082-12.0820%2.006-702%-1.875-84%-1.566-87%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---142.011--------
Intrinsic Value_10Y_min---319.042--------
Intrinsic Value_1Y_max---6.827--------
Intrinsic Value_1Y_min---16.172--------
Intrinsic Value_3Y_max---26.154--------
Intrinsic Value_3Y_min---62.562--------
Intrinsic Value_5Y_max---52.284--------
Intrinsic Value_5Y_min---123.907--------
Market Cap40427075700.000+30%28393715700.00028393715700.0000%18716888700.000+52%17651936340.000+61%15980970600.000+78%
Net Profit Margin--0.1070.1070%0.115-7%0.100+7%0.094+14%
Operating Margin----0%0.167-100%0.116-100%0.116-100%
Operating Ratio--1.3241.3240%1.318+0%1.363-3%1.369-3%
Pb Ratio7.591+30%5.3325.3320%5.381-1%6.306-15%6.942-23%
Pe Ratio46.934+30%32.96432.9640%23.483+40%25.848+28%27.333+21%
Price Per Share403.150+30%283.150283.1500%186.650+52%176.030+61%159.367+78%
Price To Free Cash Flow Ratio-33.368-42%-23.436-23.4360%-8.739-63%45.495-152%21.775-208%
Price To Total Gains Ratio21.768+30%15.28815.2880%23.474-35%20.365-25%18.649-18%
Quick Ratio--0.9200.9200%0.776+19%0.768+20%0.732+26%
Return On Assets--0.0790.0790%0.093-15%0.106-26%0.102-23%
Return On Equity--0.1620.1620%0.229-29%0.248-35%0.255-37%
Total Gains Per Share--18.52118.5210%7.951+133%9.194+101%8.921+108%
Usd Book Value--62842150.80062842150.8000%41041367.600+53%33483144.280+88%29384462.267+114%
Usd Book Value Change Per Share--0.2170.2170%0.093+135%0.108+102%0.104+108%
Usd Book Value Per Share--0.6270.6270%0.409+53%0.334+88%0.293+114%
Usd Dividend Per Share--0.0010.0010%0.001-7%0.001+28%0.001+39%
Usd Eps--0.1010.1010%0.094+8%0.077+31%0.069+47%
Usd Free Cash Flow---14296195.600-14296195.6000%-25274172.200+77%-5646797.960-61%-4860567.500-66%
Usd Free Cash Flow Per Share---0.143-0.1430%-0.252+77%-0.056-61%-0.048-66%
Usd Free Cash Flow To Equity Per Share---0.143-0.1430%0.024-702%-0.022-84%-0.018-87%
Usd Market Cap477039493.260+30%335045845.260335045845.2600%220859286.660+52%208292848.812+61%188575453.080+78%
Usd Price Per Share4.757+30%3.3413.3410%2.202+52%2.077+61%1.881+78%
Usd Profit--10163989.00010163989.0000%9405166.400+8%7758941.320+31%6897284.867+47%
Usd Revenue--95186552.60095186552.6000%81493254.400+17%73676648.840+29%68295676.167+39%
Usd Total Gains Per Share--0.2190.2190%0.094+133%0.108+101%0.105+108%
 EOD+5 -3MRQTTM+0 -0YOY+23 -125Y+24 -1110Y+24 -11

3.3 Fundamental Score

Let's check the fundamental score of GUFIC BIOSCIENCES LTD. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1546.934
Price to Book Ratio (EOD)Between0-17.591
Net Profit Margin (MRQ)Greater than00.107
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.920
Current Ratio (MRQ)Greater than11.614
Debt to Asset Ratio (MRQ)Less than10.513
Debt to Equity Ratio (MRQ)Less than11.051
Return on Equity (MRQ)Greater than0.150.162
Return on Assets (MRQ)Greater than0.050.079
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of GUFIC BIOSCIENCES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.483
Ma 20Greater thanMa 50440.943
Ma 50Greater thanMa 100418.543
Ma 100Greater thanMa 200392.284
OpenGreater thanClose414.000
Total4/5 (80.0%)

4. In-depth Analysis

4.1 About GUFIC BIOSCIENCES LTD.

Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.

Fundamental data was last updated by Penke on 2024-11-20 01:06:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is overpriced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Gufic earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 10.7% means that ₹0.11 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 10.7%. The company is making a huge profit. +2
  • The TTM is 10.7%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.7%TTM10.7%0.0%
TTM10.7%YOY11.5%-0.9%
TTM10.7%5Y10.0%+0.7%
5Y10.0%10Y9.4%+0.6%
4.3.1.2. Return on Assets

Shows how efficient Gufic is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • 7.9% Return on Assets means that Gufic generated ₹0.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 7.9%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 7.9%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ7.9%TTM7.9%0.0%
TTM7.9%YOY9.3%-1.4%
TTM7.9%5Y10.6%-2.8%
5Y10.6%10Y10.2%+0.5%
4.3.1.3. Return on Equity

Shows how efficient Gufic is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • 16.2% Return on Equity means Gufic generated ₹0.16 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 16.2%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 16.2%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ16.2%TTM16.2%0.0%
TTM16.2%YOY22.9%-6.7%
TTM16.2%5Y24.8%-8.6%
5Y24.8%10Y25.5%-0.7%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of GUFIC BIOSCIENCES LTD..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Gufic is operating .

  • Measures how much profit Gufic makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY16.7%-16.7%
TTM-5Y11.6%-11.6%
5Y11.6%10Y11.6%0.0%
4.3.2.2. Operating Ratio

Measures how efficient Gufic is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.32 means that the operating costs are ₹1.32 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 1.324. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.324. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.324TTM1.3240.000
TTM1.324YOY1.318+0.006
TTM1.3245Y1.363-0.040
5Y1.36310Y1.369-0.006
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of GUFIC BIOSCIENCES LTD..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Gufic is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 1.61 means the company has ₹1.61 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 1.614. The company is able to pay all its short-term debts. +1
  • The TTM is 1.614. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.614TTM1.6140.000
TTM1.614YOY1.610+0.004
TTM1.6145Y1.535+0.079
5Y1.53510Y1.487+0.048
4.4.3.2. Quick Ratio

Measures if Gufic is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.92 means the company can pay off ₹0.92 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.920. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.920TTM0.9200.000
TTM0.920YOY0.776+0.144
TTM0.9205Y0.768+0.152
5Y0.76810Y0.732+0.035
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of GUFIC BIOSCIENCES LTD..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Gufic assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Gufic to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.51 means that Gufic assets are financed with 51.3% credit (debt) and the remaining percentage (100% - 51.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 0.513. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.513. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.513TTM0.5130.000
TTM0.513YOY0.596-0.084
TTM0.5135Y0.576-0.064
5Y0.57610Y0.602-0.026
4.5.4.2. Debt to Equity Ratio

Measures if Gufic is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 105.1% means that company has ₹1.05 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The MRQ is 1.051. The company is able to pay all its debts with equity. +1
  • The TTM is 1.051. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.051TTM1.0510.000
TTM1.051YOY1.476-0.424
TTM1.0515Y1.488-0.437
5Y1.48810Y1.692-0.204
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings Gufic generates.

  • Above 15 is considered overpriced but always compare Gufic to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 32.96 means the investor is paying ₹32.96 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The EOD is 46.934. Based on the earnings, the company is overpriced. -1
  • The MRQ is 32.964. Based on the earnings, the company is overpriced. -1
  • The TTM is 32.964. Based on the earnings, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD46.934MRQ32.964+13.970
MRQ32.964TTM32.9640.000
TTM32.964YOY23.483+9.481
TTM32.9645Y25.848+7.116
5Y25.84810Y27.333-1.485
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The EOD is -33.368. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -23.436. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.436. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-33.368MRQ-23.436-9.932
MRQ-23.436TTM-23.4360.000
TTM-23.436YOY-8.739-14.697
TTM-23.4365Y45.495-68.931
5Y45.49510Y21.775+23.720
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Gufic is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 5.33 means the investor is paying ₹5.33 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of GUFIC BIOSCIENCES LTD.:

  • The EOD is 7.591. Based on the equity, the company is overpriced. -1
  • The MRQ is 5.332. Based on the equity, the company is overpriced. -1
  • The TTM is 5.332. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.591MRQ5.332+2.260
MRQ5.332TTM5.3320.000
TTM5.332YOY5.381-0.050
TTM5.3325Y6.306-0.974
5Y6.30610Y6.942-0.636
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets10,925,416
Total Liabilities5,599,810
Total Stockholder Equity5,325,606
 As reported
Total Liabilities 5,599,810
Total Stockholder Equity+ 5,325,606
Total Assets = 10,925,416

Assets

Total Assets10,925,416
Total Current Assets6,004,794
Long-term Assets4,920,622
Total Current Assets
Cash And Cash Equivalents 11,368
Short-term Investments 123,472
Net Receivables 3,299,353
Inventory 2,004,821
Other Current Assets 562,046
Total Current Assets  (as reported)6,004,794
Total Current Assets  (calculated)6,001,060
+/- 3,734
Long-term Assets
Property Plant Equipment 4,603,309
Long-term Assets Other 150,459
Long-term Assets  (as reported)4,920,622
Long-term Assets  (calculated)4,753,768
+/- 166,854

Liabilities & Shareholders' Equity

Total Current Liabilities3,720,489
Long-term Liabilities1,879,321
Total Stockholder Equity5,325,606
Total Current Liabilities
Short Long Term Debt 1,630,714
Accounts payable 1,662,687
Other Current Liabilities 173,600
Total Current Liabilities  (as reported)3,720,489
Total Current Liabilities  (calculated)3,467,001
+/- 253,488
Long-term Liabilities
Long term Debt 1,539,631
Capital Lease Obligations Min Short Term Debt158,812
Long-term Liabilities  (as reported)1,879,321
Long-term Liabilities  (calculated)1,698,443
+/- 180,878
Total Stockholder Equity
Total Stockholder Equity (as reported)5,325,606
Total Stockholder Equity (calculated)0
+/- 5,325,606
Other
Capital Stock100,278
Common Stock Shares Outstanding 100,278
Net Debt 3,158,977
Net Invested Capital 8,495,951
Net Working Capital 2,284,305
Property Plant and Equipment Gross 4,603,309



6.2. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
2,795,397
3,562,407
3,920,610
5,214,017
8,611,595
10,925,416
10,925,4168,611,5955,214,0173,920,6103,562,4072,795,39700
   > Total Current Assets 
1,432,465
1,982,045
2,325,135
2,733,066
2,605,828
3,207,540
4,641,086
6,004,794
6,004,7944,641,0863,207,5402,605,8282,733,0662,325,1351,982,0451,432,465
       Cash And Cash Equivalents 
0
0
36,614
41,840
62,014
116,081
286,019
11,368
11,368286,019116,08162,01441,84036,61400
       Short-term Investments 
0
0
0
0
69,765
149,631
180,848
123,472
123,472180,848149,63169,7650000
       Net Receivables 
530,749
810,216
1,034,188
1,069,723
1,245,007
1,515,529
2,054,657
3,299,353
3,299,3532,054,6571,515,5291,245,0071,069,7231,034,188810,216530,749
       Inventory 
630,163
942,010
942,846
1,224,614
944,046
1,155,669
1,834,575
2,004,821
2,004,8211,834,5751,155,669944,0461,224,614942,846942,010630,163
       Other Current Assets 
241,155
190,784
308,250
385,529
346,427
407,927
454,289
562,046
562,046454,289407,927346,427385,529308,250190,784241,155
   > Long-term Assets 
0
0
470,262
927,601
1,314,782
2,006,477
3,970,509
4,920,622
4,920,6223,970,5092,006,4771,314,782927,601470,26200
       Property Plant Equipment 
219,901
244,355
337,080
794,542
1,184,569
1,897,527
3,284,788
4,603,309
4,603,3093,284,7881,897,5271,184,569794,542337,080244,355219,901
       Goodwill 
0
0
224
210
0
0
0
0
000021022400
       Intangible Assets 
0
0
3,440
5,360
4,451
6,102
6,788
0
06,7886,1024,4515,3603,44000
       Long-term Assets Other 
0
0
378
377
-3
352,735
577,111
150,459
150,459577,111352,735-337737800
> Total Liabilities 
0
0
2,041,918
2,603,867
2,186,244
2,522,838
5,133,513
5,599,810
5,599,8105,133,5132,522,8382,186,2442,603,8672,041,91800
   > Total Current Liabilities 
1,281,771
1,685,493
1,863,433
2,397,735
1,636,624
1,864,016
2,882,075
3,720,489
3,720,4892,882,0751,864,0161,636,6242,397,7351,863,4331,685,4931,281,771
       Short Long Term Debt 
0
0
864,363
928,069
199,222
138,447
1,207,278
1,630,714
1,630,7141,207,278138,447199,222928,069864,36300
       Accounts payable 
437,387
759,794
778,051
1,170,683
1,112,147
1,409,512
2,509,924
1,662,687
1,662,6872,509,9241,409,5121,112,1471,170,683778,051759,794437,387
       Other Current Liabilities 
176,353
72,456
95,566
73,022
99,608
121,249
162,609
173,600
173,600162,609121,24999,60873,02295,56672,456176,353
   > Long-term Liabilities 
0
0
178,485
358,195
549,620
653,017
2,251,438
1,879,321
1,879,3212,251,438653,017549,620358,195178,48500
       Capital Lease Obligations Min Short Term Debt
0
0
379
96,329
61,885
31,453
227,857
158,812
158,812227,85731,45361,88596,32937900
       Long-term Liabilities Other 
0
0
1
-2
0
-1
0
0
00-10-2100
> Total Stockholder Equity
0
0
753,479
958,540
1,734,366
2,691,179
3,478,082
5,325,606
5,325,6063,478,0822,691,1791,734,366958,540753,47900
   Common Stock
77,350
77,830
77,830
96,945
96,945
96,945
96,945
0
096,94596,94596,94596,94577,83077,83077,350
   Retained Earnings Total Equity00000000
   Accumulated Other Comprehensive Income 00000000
   Capital Surplus 00000000
   Treasury Stock00000000
   Other Stockholders Equity 
1,250
1,250
1,250
684,397
687,107
695,215
694,763
0
0694,763695,215687,107684,3971,2501,2501,250



6.3. Balance Sheets

Currency in INR. All numbers in thousands.




6.4. Cash Flows

Currency in INR. All numbers in thousands.




6.5. Income Statements

Currency in INR. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2024-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue8,066,657
Cost of Revenue-3,898,952
Gross Profit4,167,7054,167,705
 
Operating Income (+$)
Gross Profit4,167,705
Operating Expense-6,778,115
Operating Income1,288,542-2,610,410
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense6,778,1150
 
Net Interest Income (+$)
Interest Income0
Interest Expense-153,599
Other Finance Cost-0
Net Interest Income-153,599
 
Pretax Income (+$)
Operating Income1,288,542
Net Interest Income-153,599
Other Non-Operating Income Expenses0
Income Before Tax (EBT)1,156,7151,288,542
EBIT - interestExpense = -153,599
861,355
1,014,954
Interest Expense153,599
Earnings Before Interest and Taxes (EBIT)01,310,314
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax1,156,715
Tax Provision-295,360
Net Income From Continuing Ops861,355861,355
Net Income861,355
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0153,599
 

Technical Analysis of Gufic
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Gufic. The general trend of Gufic is BULLISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Gufic's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (57.1%) Bearish trend (-57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of GUFIC BIOSCIENCES LTD..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 413.30 < 501.10.

The bearish price targets are: 368.11 > 357.90 > 354.56.

Tweet this
GUFIC BIOSCIENCES LTD. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of GUFIC BIOSCIENCES LTD.. The current mas is .

The long score for the Moving Averages is 11/14.
The longshort score for the Moving Averages is 8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

GUFIC BIOSCIENCES LTD. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of GUFIC BIOSCIENCES LTD.. The current macd is -0.53043076.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gufic price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Gufic. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Gufic price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
GUFIC BIOSCIENCES LTD. Daily Moving Average Convergence/Divergence (MACD) ChartGUFIC BIOSCIENCES LTD. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of GUFIC BIOSCIENCES LTD.. The current adx is 37.97.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Gufic shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
GUFIC BIOSCIENCES LTD. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of GUFIC BIOSCIENCES LTD.. The current sar is 481.98.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
GUFIC BIOSCIENCES LTD. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of GUFIC BIOSCIENCES LTD.. The current rsi is 40.48. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending down: The RSI is trending down. -1
GUFIC BIOSCIENCES LTD. Daily Relative Strength Index (RSI) ChartGUFIC BIOSCIENCES LTD. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of GUFIC BIOSCIENCES LTD.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Gufic price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
GUFIC BIOSCIENCES LTD. Daily Stochastic Oscillator ChartGUFIC BIOSCIENCES LTD. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of GUFIC BIOSCIENCES LTD.. The current cci is -130.71719284.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
GUFIC BIOSCIENCES LTD. Daily Commodity Channel Index (CCI) ChartGUFIC BIOSCIENCES LTD. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of GUFIC BIOSCIENCES LTD.. The current cmo is -30.87222591.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
GUFIC BIOSCIENCES LTD. Daily Chande Momentum Oscillator (CMO) ChartGUFIC BIOSCIENCES LTD. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of GUFIC BIOSCIENCES LTD.. The current willr is -93.19695528.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
GUFIC BIOSCIENCES LTD. Daily Williams %R ChartGUFIC BIOSCIENCES LTD. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of GUFIC BIOSCIENCES LTD..

GUFIC BIOSCIENCES LTD. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of GUFIC BIOSCIENCES LTD.. The current atr is 24.57.

GUFIC BIOSCIENCES LTD. Daily Average True Range (ATR) ChartGUFIC BIOSCIENCES LTD. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of GUFIC BIOSCIENCES LTD.. The current obv is 850,408.

GUFIC BIOSCIENCES LTD. Daily On-Balance Volume (OBV) ChartGUFIC BIOSCIENCES LTD. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of GUFIC BIOSCIENCES LTD.. The current mfi is 59.61.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
GUFIC BIOSCIENCES LTD. Daily Money Flow Index (MFI) ChartGUFIC BIOSCIENCES LTD. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for GUFIC BIOSCIENCES LTD..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-07-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-19BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-23STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-07-24STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-07-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-07-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-07-31MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-08-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-09STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-08-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-23RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-30RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-02WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-16MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-24CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-27BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-01MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-03SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-10CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-14CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-10-16BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-17RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-18BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-22RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-08BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-11-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

GUFIC BIOSCIENCES LTD. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of GUFIC BIOSCIENCES LTD. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.483
Ma 20Greater thanMa 50440.943
Ma 50Greater thanMa 100418.543
Ma 100Greater thanMa 200392.284
OpenGreater thanClose414.000
Total4/5 (80.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Gufic with someone you think should read this too:
  • Are you bullish or bearish on Gufic? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Gufic? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about GUFIC BIOSCIENCES LTD.

I send you an email if I find something interesting about GUFIC BIOSCIENCES LTD..


Comments

How you think about this?

Leave a comment

Stay informed about GUFIC BIOSCIENCES LTD..

Receive notifications about GUFIC BIOSCIENCES LTD. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.